Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04340531 · ClinicalTrials.gov registry record · NA

Effectiveness of a Multi-Level Smoking Cessation Program for High-Risk Women in Rural Communities

A NA study of Tobacco-Related Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
810
Enrollment target
4
Study locations

NCT04340531: Active NA study of Tobacco-Related Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

NCT04340531 is a NA study of Tobacco-Related Carcinoma that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 810 participants, below the 1,428-participant average among 10 other Tobacco-Related Carcinoma trials with a reported enrollment target (43% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04340531, a NA study of Tobacco-Related Carcinoma, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
810 participants
Enrollment target
4
Study locations

Study Summary

This phase IV trial examines the effectiveness of a multi-level smoking cessation program for high-risk women in rural communities. Cigarette smoking is a major risk factor for cervical cancer in women. Rural primary care practices and providers often lack the electronic health record support to pre-identify smokers for services, as well as lack the necessary counseling training and access to comprehensive cessation programs. Implementing evidence-based smoking cessation programs in rural Appalachia may decrease the rates of cigarette smoking and as a result decrease the rates of cervical cancer.

Primary Outcome

This provider-level outcome includes self-reported changes in the delivery of the Ask, Advise, and Connect (AAC).

Conditions Studied

Interventions

  • OTHER Survey Administration
  • OTHER Best Practice
  • OTHER Tobacco Cessation Counseling
  • OTHER Training

Study Locations (4)

Kentucky

  • University of Kentucky/Markey Cancer Center - Lexington

Ohio

  • Ohio State University Comprehensive Cancer Center - Columbus

Virginia

  • University of Virginia - Charlottesville

West Virginia

  • West Virginia University - Morgantown

Trial Details

FieldValue
Enrollment Target 810 participants
Start Date 2021-01-30
Est. Completion 2026-05-31
Phase NA

What the registry record for NCT04340531 still lists

NCT04340531 is an interventional study that assigns participants to a tested intervention. The registered 810 participants enrollment target is mid-sized for trials with a published cap, below the 1,428-participant average among 10 other Tobacco-Related Carcinoma trials with a reported enrollment target (43% lower).

The record links to 1 condition, with Tobacco-Related Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Survey Administration is the first listed.

NCT04340531 reports a single indexed study location in Kentucky, Ohio, Virginia.

Frequently Asked Questions

What is clinical trial NCT04340531 about?

NCT04340531 is a clinical study titled "Effectiveness of a Multi-Level Smoking Cessation Program for High-Risk Women in Rural Communities". This phase IV trial examines the effectiveness of a multi-level smoking cessation program for high-risk women in rural communities. Cigarette smoking is a major risk factor for cervical cancer in women. Rural primary care practices and providers often lack the electronic health record support to pre...

What is the current status of trial NCT04340531?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 810 participants. The study started on 2021-01-30. Estimated completion is 2026-05-31.

What conditions does trial NCT04340531 study?

This clinical trial studies the following conditions: Tobacco-Related Carcinoma.

What interventions are being tested in trial NCT04340531?

The interventions under investigation include: Survey Administration (OTHER), Best Practice (OTHER), Tobacco Cessation Counseling (OTHER), Training (OTHER).

Who is sponsoring clinical trial NCT04340531?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04340531 being conducted?

This trial has 4 study locations across Kentucky, Ohio, Virginia, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco-Related Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04340531's enrollment target sits among peer trials

810 4th of 10 higher than 7 of 10 other Tobacco-Related Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco-Related Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05519085 · 810 participants · Phase 3

    A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

  • NCT06529094 · 808 participants · NA

    Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic

  • NCT04613596 · 806 participants · Phase 2

    Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  • NCT06065098 · 806 participants · NA

    Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04340531, the US trial registry maintained by the National Library of Medicine. NCT04340531 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.